Treatment-refractory cutaneous Rosai-Dorfman disease responsive to oral methotrexate and topical trametinib - Christopher J. Fay, BA; Dorsa Moslehi, BA; Christopher Iriarte, MD; Timothy M. Dang, MD; Cesar A. Virgen, MD, PhD; Eleanor Russell-Goldman, MD, PhD; Nicole R. LeBoeuf, MD, MPH (Elsevier, 2023)